- Home
- PFE
PFE
Pfizer Inc.
as 07-26-2024 4:00pm EST
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
Upcoming Earnings Alert:
Get ready for potential market movements as Pfizer Inc. PFE prepares to release earnings report on 30 Jul 2024.
| Founded: | 1849 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 158.9B | IPO Year: | N/A |
| Target Price: | $34.50 | AVG Volume (30 days): | 31.6M |
| Analyst Decision: | Buy | Number of Analysts: | 13 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | -0.05 | EPS Growth: | N/A |
| 52 Week Low/High: | $25.20 - $37.19 | Next Earning Date: | 07-30-2024 |
| Revenue: | $55,094,000,000 | Revenue Growth: | -40.86% |
| Revenue Growth (this year): | 4.61% | Revenue Growth (next year): | 3.61% |
Stock Insider Trading Activity of Pfizer Inc. (PFE)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Gottlieb Scott | PFE | Director | Dec 15 '23 | Buy | $26.47 | 3,000 | $79,401.00 | 9,000 | SEC Form 4 |
Latest Pfizer Inc. News
PFE Breaking Stock News: Dive into PFE Ticker-Specific Updates for Smart Investing
Motley Fool
8 hours ago
3 Surprisingly Underrated Stocks to Buy Right Now
Zacks
10 hours ago
Pharma Stock Roundup: AZN, SNY, ABBV Q2 Earnings, PFE & MRK's Positive Pipeline News
Zacks
11 hours ago
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know
MT Newswires
12 hours ago
Merck's Combination Urinary Cancer Therapy Receives EMA's Committee Nod
Pharmaceutical Technology
16 hours ago
EC conditionally approves Pfizer’s haemophilia B gene therapy
Barrons.com
17 hours ago
This Biotech Risk-Taker Created Moderna. Now He’s Harnessing AI.
Benzinga
a day ago
How To Earn $100 Per Month From Pfizer Stock
MT Newswires
a day ago
Pfizer's Hemophilia B Treatment Gets Conditional Marketing Authorization in Europe
Compare PFE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PFE Pfizer Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.